These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 12473880)
1. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. de Vos tot Nederveen Cappel WH; Nagengast FM; Griffioen G; Menko FH; Taal BG; Kleibeuker JH; Vasen HF Dis Colon Rectum; 2002 Dec; 45(12):1588-94. PubMed ID: 12473880 [TBL] [Abstract][Full Text] [Related]
2. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Park JG; Vasen HF; Park KJ; Peltomaki P; Ponz de Leon M; Rodriguez-Bigas MA; Lubinski J; Beck NE; Bisgaard ML; Miyaki M; Wijnen JT; Baba S; Lynch HT Dis Colon Rectum; 1999 Jun; 42(6):710-5; discussion 715-6. PubMed ID: 10378593 [TBL] [Abstract][Full Text] [Related]
3. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer. Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904 [TBL] [Abstract][Full Text] [Related]
4. In a resource-poor country, mutation identification has the potential to reduce the cost of family management for hereditary nonpolyposis colorectal cancer. Goldberg PA; Madden MV; Harocopos C; Felix R; Westbrook C; Ramesar RS Dis Colon Rectum; 1998 Oct; 41(10):1250-3; discussion 1253-5. PubMed ID: 9788388 [TBL] [Abstract][Full Text] [Related]
5. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431 [TBL] [Abstract][Full Text] [Related]
6. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786 [TBL] [Abstract][Full Text] [Related]
7. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016 [TBL] [Abstract][Full Text] [Related]
8. Hereditary non-polyposis colorectal cancer (HNPCC): new germline mutation (190-191 del AA) in the human MLH1 gene and review of clinical guidelines for surveillance of affected families. Schiemann U; Papatheodorou L; Glasl S; Gross M Eur J Med Res; 2001 Mar; 6(3):93-100. PubMed ID: 11309221 [TBL] [Abstract][Full Text] [Related]
9. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
10. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population. Shashidharan M; Smyrk T; Lin KM; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lynch HT Dis Colon Rectum; 1999 Jun; 42(6):722-6. PubMed ID: 10378595 [TBL] [Abstract][Full Text] [Related]
11. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610 [TBL] [Abstract][Full Text] [Related]
12. Germline mutations of hMLH1 and hMSH2 genes in patients with suspected hereditary nonpolyposis colorectal cancer and sporadic early-onset colorectal cancer. Yuan Y; Han HJ; Zheng S; Park JG Dis Colon Rectum; 1998 Apr; 41(4):434-40. PubMed ID: 9559627 [TBL] [Abstract][Full Text] [Related]
13. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Syngal S; Weeks JC; Schrag D; Garber JE; Kuntz KM Ann Intern Med; 1998 Nov; 129(10):787-96. PubMed ID: 9841584 [TBL] [Abstract][Full Text] [Related]
14. Patterns of surgery in patients belonging to amsterdam-positive families. Van Dalen R; Church J; McGannon E; Fay S; Burke C; Clark B Dis Colon Rectum; 2003 May; 46(5):617-20. PubMed ID: 12792437 [TBL] [Abstract][Full Text] [Related]
15. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626 [TBL] [Abstract][Full Text] [Related]
16. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Hendriks YM; Wagner A; Morreau H; Menko F; Stormorken A; Quehenberger F; Sandkuijl L; Møller P; Genuardi M; Van Houwelingen H; Tops C; Van Puijenbroek M; Verkuijlen P; Kenter G; Van Mil A; Meijers-Heijboer H; Tan GB; Breuning MH; Fodde R; Wijnen JT; Bröcker-Vriends AH; Vasen H Gastroenterology; 2004 Jul; 127(1):17-25. PubMed ID: 15236168 [TBL] [Abstract][Full Text] [Related]
17. Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands. Vasen HF; den Hartog Jager FC; Menko FH; Nagengast FM Am J Med; 1989 Mar; 86(3):278-81. PubMed ID: 2919609 [TBL] [Abstract][Full Text] [Related]
18. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220 [TBL] [Abstract][Full Text] [Related]
19. Clinical implications of molecular diagnosis in hereditary nonpolyposis colorectal cancer. Möslein G Recent Results Cancer Res; 2003; 162():73-8. PubMed ID: 12790322 [TBL] [Abstract][Full Text] [Related]